Additionally, Serca2 silencing also increased the protein levels of p-eIF2α and p-JNK, while it effectively blocked AT-II's ability to inhibit these proteins in AML-12 cells incubated with PA (Figs. 10F and G). Here, EIF2A is linked to acute myeloid leukemia.